Pay in 4 interest-free payments of $5.15 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
GLP-1 receptor agonists are administered subcutaneously into the abdomen, thigh, or upper arm with no clinically relevant absorption differences between sites
Pinch approximately 2 to 5 cm of skin to lift the subcutaneous tissue away from underlying muscle
How to Apply Apply directly to the scalp, focusing on thinning areas
189 Subsequently, tirzepatide has been extensively investigated in the SURPASS program, a comprehensive development initiative targeting T2DM that is inadequately controlled by various glucose-lowering regimens, including lifestyle alone (SURPASS-1), 190 metformin monotherapy (SURPASS-2), 191 metformin with or without sodium-glucose co-transporter 2 inhibitors (SGLT2i) (SURPASS-3), 192 combination therapy including metformin, SGLT2i, and sulfonylureas (SURPASS-4), 193 insulin glargine with or without metformin (SURPASS-5), 88 and insulin lispro with basal insulin (SURPASS-6)
Some clinical trials have confirmed that the combination of metformin and DPP-4i is safe and effective in controlling serum glucose and HbA1c, in addition to having beneficial effects on the cardiovascular system
The primary difference between Zepbound and Mounjaro is the indication on the label
US$ 29.32
US$ 24.41
US$ 20.87
US$ 24.23
US$ 23.22
US$ 22.76
